Asston Pharmaceuticals Ltd — Important, 06-01-2026: Company Update

Asston Pharmaceuticals has confirmed compliance for the latest quarter concerning share dematerialisation processes. The company's Registrar and Share Transfer Agent ensured that all requests for converting physical shares into electronic format were correctly processed with depositories and subsequently listed. This confirms that shareholder records are accurately updated and maintained promptly. This update is crucial for investor confidence, ensuring seamless and efficient management of shareholdings in line with market operational guidelines.